Analysis of pr- ram of porcine cardiac ischemia and the recovery process in coronary arterial occlusion and recanalization using 31P-MRS
31P-MRS分析猪心肌缺血的PRRAM及冠状动脉闭塞再通的恢复过程
基本信息
- 批准号:62480215
- 负责人:
- 金额:$ 4.16万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (B)
- 财政年份:1987
- 资助国家:日本
- 起止时间:1987 至 1988
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
In an attempt to define the metabolic abnormalities of ischemic myocardium, the changes in high energy phoshates, inorganic phosphate and intracellular pH were serially and quantitatively evealuated in ischemic porcine hearts habing no collateral circulation using arterial pressure and respiration gated in vivo 31P magnetic resonance spectroscopy. The protocol was also modified for propranolol pretreatment (o.6mg/kg i.v.) and carteolol pre-and post-treatment (10mug/kg i.v.) as beta-blockers and verapamil (200mug/kg) to define their effects on the metabollsm of ischemic myocardium. In the non-treated group, creatine phosphate was repidly depleted by 20 miutes after ischemia; by 40 minutes, ATP and inttacellular pH gradually decreased to 10 11% of control and to 5.90 0.26, respectively, and inorganic phosphate rose to 303 43% of control. In the propranolol, and verapamil and carteolol pre-treated-group, the concentrations of ATP were higher at 20 minute occlusion, and the protective effect disappeared at 40 minute occlusion. There was no significant difference of double product between control and treated groups. This suggests that the beneficial effect of beta-blocker and Ca antagonist on ischemic myocardium is due to direct effect to viable ischemic myocytes. In reperfusion after 20 minute occlusion, creatine phosphate, pH and inorganic phosphate were normalized rapidly. In control and post treated group, ATP level did not change ecen in 120 minute reperfusion. In pretreated group, however, the concentration of ATP was normalized after 120 minute of reperfusion. This suggested that the beneficial effect is due to the protective effect during occlusion.
为探讨缺血心肌的代谢异常,应用在体动脉压门控和呼吸门控31 P磁共振波谱技术,对无侧支循环的缺血猪心高能磷酸盐、无机磷酸盐和细胞内pH值的变化进行了动态定量研究。方案也针对普萘洛尔预处理(0.6mg/kg i. v.)和卡替洛尔治疗前和治疗后(10 μ g/kg i. v.)β-受体阻滞剂和维拉帕米(200 μ g/kg),以确定它们对缺血心肌代谢的影响。在非治疗组,磷酸肌酸迅速耗尽缺血后20分钟,40分钟,ATP和intattacellular pH值逐渐下降到10 - 11%的控制和5.90 - 0.26,分别,和无机磷酸盐上升到303 - 43%的控制。普萘洛尔、维拉帕米和卡替洛尔预处理组ATP浓度在阻断20分钟时较高,阻断40分钟时保护作用消失。对照组和治疗组的双乘积无显著差异。这表明β受体阻滞剂和Ca拮抗剂对缺血心肌的有益作用是由于对存活的缺血心肌细胞的直接作用。再灌注20分钟后,磷酸肌酸,pH和无机磷酸盐迅速恢复正常。再灌注120分钟后,对照组和后处理组的ATP水平无明显变化。预处理组再灌注120分钟后ATP浓度恢复正常。这表明,有益效果是由于闭塞期间的保护作用。
项目成果
期刊论文数量(41)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
FUJIWARA Hisayoshi其他文献
FUJIWARA Hisayoshi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('FUJIWARA Hisayoshi', 18)}}的其他基金
Development of Integrated Backscatter Ultrasound System for Tissue Characterization
用于组织表征的集成反向散射超声系统的开发
- 批准号:
15590731 - 财政年份:2003
- 资助金额:
$ 4.16万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Non-invasive regeneration therapy of dilated cardiomyopathy using G-CSF
使用G-CSF对扩张型心肌病进行无创再生治疗
- 批准号:
15209027 - 财政年份:2003
- 资助金额:
$ 4.16万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
New In Vivo Apoptosis Model of Cardiomyocytes and Bcl-2 gene therapy
新的体内心肌细胞凋亡模型和Bcl-2基因治疗
- 批准号:
13470143 - 财政年份:2001
- 资助金额:
$ 4.16万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Protective effect of α -1, 6-glucosidase inhibitors against ischemia-reperfusionjury
α -1, 6-葡萄糖苷酶抑制剂对缺血再灌注损伤的保护作用
- 批准号:
11557049 - 财政年份:1999
- 资助金额:
$ 4.16万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
Gene therapy against restenosis after balloom injury using apoptosis inducer, bax
使用细胞凋亡诱导剂 bax 对抗球囊损伤后再狭窄的基因治疗
- 批准号:
11470160 - 财政年份:1999
- 资助金额:
$ 4.16万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
Pathophysiological role and mechanism of apoptosis in human congestive heart hailure
细胞凋亡在人充血性心雹中的病理生理作用及机制
- 批准号:
09470165 - 财政年份:1997
- 资助金额:
$ 4.16万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
相似海外基金
Genome instability induced by high-energy phosphate compounds
高能磷酸化合物引起的基因组不稳定
- 批准号:
16K16195 - 财政年份:2016
- 资助金额:
$ 4.16万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Basic Fibroblast growth factor improves high energy phosphate metabolism in the ischemic myocardium in rabbits
碱性成纤维细胞生长因子改善兔缺血心肌高能磷酸盐代谢
- 批准号:
11670719 - 财政年份:1999
- 资助金额:
$ 4.16万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
NONLINEAR MODELING OF MYOCARDIAL HIGH ENERGY PHOSPHATE SYSTEM
心肌高能磷酸盐系统的非线性建模
- 批准号:
6119771 - 财政年份:1998
- 资助金额:
$ 4.16万 - 项目类别:
^<31>P Chemical Shift Imaging for Quantitative Measurements of Cardiac High-Energy Phosphate
^<31>用于心脏高能磷酸盐定量测量的 P 化学位移成像
- 批准号:
06670711 - 财政年份:1994
- 资助金额:
$ 4.16万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
HIGH ENERGY PHOSPHATE METABOLISM IN NORMAL AND ISCHEMIC
正常和缺血状态下的高能磷酸盐代谢
- 批准号:
3050269 - 财政年份:1986
- 资助金额:
$ 4.16万 - 项目类别:
REGULATION OF HEART HIGH-ENERGY PHOSPHATE METABOLISM
心脏高能磷酸盐代谢的调节
- 批准号:
3345620 - 财政年份:1985
- 资助金额:
$ 4.16万 - 项目类别:
REGULATION OF HEART HIGH-ENERGY PHOSPHATE METABOLISM
心脏高能磷酸盐代谢的调节
- 批准号:
3345618 - 财政年份:1985
- 资助金额:
$ 4.16万 - 项目类别:
REGULATION OF HEART HIGH-ENERGY PHOSPHATE METABOLISM
心脏高能磷酸盐代谢的调节
- 批准号:
3345621 - 财政年份:1985
- 资助金额:
$ 4.16万 - 项目类别: